Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial

Viviany R Taqueti1,2, Amil M Shah1,2, Brendan M Everett2,3

  • 1Cardiovascular Imaging Program, Departments of Medicine and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Insights

Inflammation impacts cardiovascular health. In patients with cardiometabolic disease, reduced coronary flow reserve (CFR) linked to inflammation, suggesting microvascular ischemia may contribute to heart failure.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Heart Failure Pathophysiology

Background:

  • Inflammation is a critical factor in cardiovascular disease outcomes.
  • The precise role of inflammation in the development of heart failure remains unclear.
  • Understanding inflammation's impact on cardiac function is vital for patient care.

Purpose of the Study:

  • To investigate the association between coronary flow reserve (CFR) and inflammation in patients with cardiometabolic disease.
  • To determine if inflammation modifies the relationship between cardiac blood flow and myocardial strain.
  • To explore the potential link between inflammation-mediated microvascular ischemia and heart failure.

Main Methods:

  • Analysis of data from the prospective, multicenter Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR) study, an ancillary study of the Cardiovascular Inflammation Reduction Trial (CIRT).
  • Assessment of coronary flow reserve (CFR) in patients with cardiometabolic disease.
  • Evaluation of inflammation markers and myocardial strain.
  • Statistical analysis to identify independent associations and interactions.

Main Results:

  • Impaired coronary flow reserve (CFR) was independently associated with increased inflammation and myocardial strain.
  • These associations persisted despite well-controlled lipid, glycemic, and hemodynamic profiles.
  • Inflammation was found to modify the relationship between CFR and myocardial strain, disrupting the link between cardiac blood flow and function.

Conclusions:

  • In patients with cardiometabolic disease, impaired CFR is linked to heightened inflammation and myocardial strain.
  • Inflammation appears to disrupt the normal relationship between cardiac blood flow and function.
  • Further research is warranted to confirm if inflammation-driven microvascular ischemia, indicated by reduced CFR, predicts heart failure development.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
18
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19